GFP-LC3 High-Content Assay for Screening Autophagy Modulators
Authors:
- 16 March 2022
- book chapter
- Published by Springer Nature
- Vol. 2474, 83-89
Abstract
Autophagy plays an important role in maintaining cellular homeostasis. Defects in autophagy have been linked to various human diseases, such as cancer, neurodegenerative diseases, and cardiovascular diseases. Therefore, it is useful to develop an assay that can measure the functions of autophagy and also be used to identify autophagy modulators by screening a large number of compounds. This chapter describes a cell-based high content green fluorescent protein (GFP)-LC3 assay using mouse embryonic fibroblasts (MEF) stably expressing GFP-LC3.Keywords
This publication has 10 references indexed in Scilit:
- Biological activity-based modeling identifies antiviral leads against SARS-CoV-2Nature Biotechnology, 2021
- Autophagy Induction as a Therapeutic Strategy for Neurodegenerative DiseasesJournal of Molecular Biology, 2020
- Targeting autophagy in cancerNature Reviews Cancer, 2017
- A cell-based quantitative high-throughput image screening identified novel autophagy modulatorsPharmacological Research, 2016
- Choose Delicately and Reuse Adequately: The Newly Revealed Process of AutophagyBiological and Pharmaceutical Bulletin, 2015
- Autophagy: Renovation of Cells and TissuesCell, 2011
- Autophagy and AgingCell, 2011
- Dissecting the dynamic turnover of GFP-LC3 in the autolysosomeAutophagy, 2011
- Methods in Mammalian Autophagy ResearchCell, 2010
- Autophagy revisited: A conversation with Christian de DuveAutophagy, 2008